Company Data

NextCure Inc.

Ticker
NXTC
Current Price
$0.7698 1.65%
Market Cap
$21.6M
Price Target
Refer to Report
Volume
13.2K
52wk Range
$0.6603 - $2.57
Advanced Market Data

Overview

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. It is focused on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. The company’s product candidate, NC318, is an immunomedicine against an immunomodulatory receptor called Siglec-15, or S15.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy